Improving the guidelines for Informed Consent

i-CONSENT, funded by the European Union H2020 programme, aims to improve the information that patients receive from clinical studies. Within the project, a series of guidelines to improve Informed Consent process will be created, including vulnerable populations, under a gender perspective and relying on ICT tools.

Project guidelines now available!

The i-CONSENT Project publishes its final product: "Guidelines for tailoring the informed consent process in clinical studies" Fragment of the guidelines. The i-CONSENT Guidelines are now ready and available for academia, clinical investigators, pharmaceutical...

read more
Visit our Twitter and get the latest content!
@ICONSENTEU

#WorldBioethicsDay | Informed consent (IC) is essential to safeguarding #autonomy, a fundamental ethical principle that should guide the clinical research.

➡️A recent publication carried out by the #iCONSENT reflects upon how to improve its understanding

https://pubmed.ncbi.nlm.nih.gov/34645425/

Load More...

i-CONSENT in Numbers

From 2017 to 2021

Partners

Million EU Funding

Countries

Years Duration

Multimedia

 i-CONSENT falls under the ‘Science with and for Society’ (SWAFS) programme, which means that on of our main goals is unlocking science for use by the wider public. i-CONSENT is committed to improving citizens’ health literacy not only as a solution to make science more attractive to them but also as a way of empowering them. This section will offer visitors and stakeholders information on the project, in particular, and  knowledge on clinical trials, research and ethics, in general.